Halozyme Therapeutics (HALO) Up 8.7% Since Last Earnings Report: Can It Continue?
Yahoo Finance · 4 days ago
Open | 49.27 |
High | 51.60 |
Low | 49.17 |
Mkt Cap | 6.53B |
P/E (TTM) | 21.29 |
Div & Yield | N/A & N/A |
Prev. Close | 50.85 |
52 Wk. Low | 32.78 |
52 Wk. High | 53.00 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 195.88M | 20.80% ▲ |
Net Income | 76.82M | 93.90% ▲ |
Diluted EPS | 0.79 | 106.90% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.78 | - |
Q1 2024 | $0.69 | $0.79 |
Q4 2023 | $0.82 | $0.82 |
S&P 500^GSPC | 5,347.64+0.65 (+0.01%) |
Dow 30^DJI | 38,724.31-74.68 (-0.19%) |
Nasdaq^IXIC | 17,162.19+29.07 (+0.17%) |
121.82+0.77% | |
380.54+9.00% | |
30.01+8.16% |